AI is now part of our everyday nomenclature, but few companies truly embrace its capabilities. At GTC we have collaborated with the top minds in the field of AI to develop our genomic interpretation software and our customers reap the benefits.
Our AI helps us sort through and curate large sets of data so we can quickly make sense of genomic alterations and assess their impact on a patient’s diagnosis, prognosis, and help predict their response to therapy.
Every result is added to our database of genomic knowledge which helps us further refine our tests and better help our customers practice precision medicine. We use machine learning to review these alterations constantly and track their frequency allowing us to gain new insights about cancer.
Genomic Sequencing Revolutionary Methods never used before. Next generation sequencing has changed medicine in the past decade in ways most people couldn’t imagine. It has allowed a rapid evolution to the field of precision medicine with new drugs being approved regularly.
In the case of Anthology Diagnostics, our partnership with Genomic Testing Cooperative means that our labs work together with physicians and patients to improve the communities access to cutting edge healthcare. Anthology Diagnostics performs on-site genome sequencing and uploads the genomic data to GTC. GTC then uses their algorithms to analyze and interpret the data, creating usable information and generating a report that will help the treating physician develop a personalized care plan for the patient.
Our AI helps us sort through curate large sets of data so we can quickly make sense of genomic alterations and assess their impact on a patient prognosis, diagnosis and help predict their response to therapy. We use machine learning to review these alterations and track their frequency allowing us to gain new insights about cancer.